You have 9 free searches left this month | for more free features.

bevacizumab-irdye800cw

Showing 1 - 12 of 12

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Thyroid Carcinoma, Surgery Trial in Groningen (Bevacizumab-IRDye800CW)

Enrolling by invitation
  • Thyroid Carcinoma
  • Surgery
  • Bevacizumab-IRDye800CW
  • Groningen, Netherlands
    University Medical Center Groningen
Oct 18, 2023

Age-Related Macular Degeneration Trial (Bevacizumab-IRDye800CW, Vedolizumab-IRDye800CW)

Not yet recruiting
  • Age-Related Macular Degeneration
  • (no location specified)
May 19, 2022

Breast Cancer Trial (Bevacizumab-IRDye800CW)

Withdrawn
  • Breast Cancer
  • Bevacizumab-IRDye800CW
  • (no location specified)
Apr 28, 2022

Esophageal Cancer Trial in Groningen (Bevacizumab-IRDye800CW, Molecular Fluorescence Endoscopy platform)

Recruiting
  • Esophageal Cancer
  • Bevacizumab-IRDye800CW
  • Molecular Fluorescence Endoscopy platform
  • Groningen, Netherlands
    University Medical Center Groningen
May 19, 2022

Pituitary Tumor, Pituitary Adenoma, Pituitary Macroadenoma Trial in Groningen (Bevacizumab-IRDye800CW, Molecular Fluorescence

Recruiting
  • Pituitary Tumor
  • +2 more
  • Bevacizumab-IRDye800CW
  • Molecular Fluorescence Endoscopy platform
  • Groningen, Netherlands
    University Medical Center Groningen
Aug 31, 2021

Hilar Cholangiocarcinoma Trial in Groningen (Bevacizumab-IRDye800CW, near infrared (NIR) fluorescence imaging)

Recruiting
  • Hilar Cholangiocarcinoma
  • Bevacizumab-IRDye800CW
  • near infrared (NIR) fluorescence imaging
  • Groningen, Netherlands
    University Medical Center Groningen
Apr 27, 2021

Barrett Esophagus Trial in Groningen (Bevacizumab-IRDye800CW, Fluorescence endoscopy)

Recruiting
  • Barrett Esophagus
  • Bevacizumab-IRDye800CW
  • Fluorescence endoscopy
  • Groningen, Netherlands
    University Medical Center Groningen
Nov 3, 2020

Soft Tissue Sarcoma Trial in Groningen (Bevacizumab-IRDye800CW)

Completed
  • Soft Tissue Sarcoma
  • Bevacizumab-IRDye800CW
  • Groningen, Netherlands
    University Medical Center Groningen
Jan 27, 2020

Rectal Cancer Trial in Groningen (Bevacizumab-IRDye800CW, NIR fluorescence endoscopy)

Completed
  • Rectal Cancer
  • Bevacizumab-IRDye800CW
  • NIR fluorescence endoscopy
  • Groningen, Netherlands
    University Medical Centre Groningen
Nov 23, 2017

Breast Cancer Trial in Groningen (bevacizumab-IRDye800CW)

Completed
  • Breast Cancer
  • bevacizumab-IRDye800CW
  • Groningen, Netherlands
    University Medical Center Groningen
Oct 25, 2017

Esophageal Cancer, Dysplasia Trial in Groningen (Bevacizumab-IRDye800CW, Near infrared fluorescence endoscopy platform)

Completed
  • Esophageal Cancer
  • Dysplasia
  • Bevacizumab-IRDye800CW
  • Near infrared fluorescence endoscopy platform
  • Groningen, Netherlands
    University Medical Center Groningen
Nov 23, 2016

Adenomatous Polyposis Coli Trial in Groningen (Bevacizumab-IRDye800CW, Near infrared fluorescence endoscopy platform)

Completed
  • Adenomatous Polyposis Coli
  • Bevacizumab-IRDye800CW
  • Near infrared fluorescence endoscopy platform
  • Groningen, Netherlands
    University Medical Center Groningen
Jan 8, 2016